Russia Sets Ground Rules for Digital Medicine With First AI Standard
Russia has introduced its first national standard directly addressing artificial intelligence in healthcare, establishing a common framework for defining, classifying, and deploying AI systems in clinical practice.
As of February 1, 2026, Russia has enacted the national standard GOST R 72484-2025, “Artificial Intelligence Systems in Healthcare. Terms and Definitions. Classification.”
The standard divides AI systems into two primary categories. The first includes solutions used directly in clinical care, such as diagnostics, treatment, rehabilitation, patient monitoring, and research. The second covers support services, including voice assistants, chatbots, and video analytics systems.
The document also defines levels of autonomy. Fully autonomous systems can independently make decisions, such as analyzing medical images or performing certain procedures. Partially autonomous systems operate independently but require physician oversight. “Second opinion” systems assist clinicians in decision-making, while analytical systems process large datasets for research and management purposes.
Importantly, these definitions are now consolidated into a unified framework rather than scattered across multiple documents.
Clinical Care Is Not an Experiment
At first glance, the standard may appear procedural, just another regulatory document. In practice, however, such frameworks significantly influence how the medical AI sector develops.
Until now, Russia’s medical AI market has expanded rapidly but without consistent structure. Companies used different terminology, described capabilities inconsistently, and followed varied implementation pathways. The new standard establishes a shared language, making it easier to compare solutions, assess quality, and distinguish between support tools and clinical technologies.
In healthcare, where the cost of error is high, this level of clarity is essential. Digital tools must be transparent, reliable, and clearly defined.
What It Means for Clinicians and Patients
For patients, these changes may not be immediately visible, but they underpin safer adoption of digital technologies. Clear classification makes it easier to regulate quality and define how different systems can be used, whether independently or as clinical support tools.
This reduces risk. Patients do not need to navigate technical details because regulatory systems provide that assurance. Clinicians gain access to tools they can trust, supported by consistent and transparent requirements. At the same time, clearer rules accelerate adoption. When regulatory pathways are defined, technologies move more quickly from pilot stages into real-world clinical use.
What It Means for Russia
For the country, the standard marks a step toward a more mature digital healthcare ecosystem. Clear regulatory frameworks enable the sector to operate within defined rules, supporting both safety and long-term technological development. Companies gain clarity on development pathways and can plan investments over multi-year horizons.
The standard also lowers barriers for new developers. It becomes easier to navigate requirements, prepare documentation, and bring products to market. Over time, this fosters not just isolated solutions but an integrated ecosystem where technology, healthcare delivery, and regulation are aligned.
Outlook and Export Potential
Domestically, the impact of the new standard will be felt quickly. It streamlines the path from development to deployment, moving technologies from concept and testing to certification, procurement, and clinical use.
In the coming years, more specialized standards are likely to emerge, targeting specific categories of medical AI and research applications. At the same time, the number of solutions achieving regulatory approval and entering clinical practice is expected to grow.
On the international front, the picture is more complex. The GOST standard itself does not automatically open access to foreign markets, but it strengthens the maturity of export-ready products. This, in turn, supports global expansion by making solutions easier to adapt to regulatory requirements in other countries.
As a result, AI in healthcare in Russia is shifting from experimental use to a structured system where technologies can be developed, validated, and safely deployed at scale.
